← Back to Search

PRO Integration into Clinical Practice for Rheumatic Diseases

N/A

Waitlist Available

Led By Dinesh Khanna, MD, MSc

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial will test whether giving patients their PROMIS scores before appointments will help them better understand and manage their health.

Eligible Conditions

Rheumatic Diseases

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of appointments at which Patient-Reported Outcomes Measurement Information System (PROMIS) scores are documented in the electronic medical record (EMR) note by the participating health care provider (HCP)

Secondary outcome measures

Change in score of the most bothersome PROMIS domain

Percent of appointments at which referrals/recommendations related to PROMIS scores are documented in the EMR note by the participating HCP

Quality of patient-provider communication

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PRO Integration into Clinical PracticeExperimental Treatment1 Intervention

PRO scores will be shared with patients and healthcare providers (HCPs) via an emailed report card

Group II: Usual CareActive Control1 Intervention

Patients and HCPs will not receive an emailed PROMIS score report. PROMIS scores, however, will be available in the EMR as usual.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PRO Integration into Clinical Practice

2021

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,795 Previous Clinical Trials

6,373,826 Total Patients Enrolled

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

483 Previous Clinical Trials

1,086,830 Total Patients Enrolled

6 Trials studying Rheumatic Diseases

8,762 Patients Enrolled for Rheumatic Diseases

Dinesh Khanna, MD, MScPrincipal InvestigatorUniversity of Michigan

1 Previous Clinical Trials

17 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study accepting participants at the present time?

"Affirmative. Per the clinicaltrials.gov website, this research is accepting new volunteers for participation. The trial was unveiled on September 14th 2021 and recently revised on August 24th 2022. This scientific venture needs approximately 500 participants from a single medical center to proceed with its investigation."

Answered by AI

How many subjects are actively participating in this investigation?

"Affirmative. Per the information found on clinicaltrials.gov, this research study is actively seeking volunteers and was first posted September 14th 2021; it has since been updated August 24th 2022. 500 participants need to be recruited for this trial at a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice

Dinesh Khanna, MD, MS 2021. "Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05026853.